Handelsbanken Fonder AB Invests $3.94 Million in Cellebrite DI Ltd. (NASDAQ:CLBT)

Handelsbanken Fonder AB acquired a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 178,700 shares of the company’s stock, valued at approximately $3,937,000. Handelsbanken Fonder AB owned 0.09% of Cellebrite DI at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Juncture Wealth Strategies LLC increased its holdings in shares of Cellebrite DI by 0.8% in the fourth quarter. Juncture Wealth Strategies LLC now owns 60,003 shares of the company’s stock valued at $1,322,000 after buying an additional 505 shares in the last quarter. Strategic Advisors LLC increased its position in Cellebrite DI by 3.4% during the fourth quarter. Strategic Advisors LLC now owns 29,082 shares of the company’s stock worth $641,000 after buying an additional 950 shares during the last quarter. Tower View Wealth Management LLC grew its position in shares of Cellebrite DI by 1.2% in the third quarter. Tower View Wealth Management LLC now owns 130,647 shares of the company’s stock valued at $2,200,000 after purchasing an additional 1,500 shares during the last quarter. Quarry LP acquired a new stake in shares of Cellebrite DI in the third quarter valued at about $27,000. Finally, Advisors Asset Management Inc. grew its position in Cellebrite DI by 130.5% during the third quarter. Advisors Asset Management Inc. now owns 3,077 shares of the company’s stock worth $52,000 after buying an additional 1,742 shares in the last quarter. 45.88% of the stock is currently owned by institutional investors and hedge funds.

Cellebrite DI Stock Up 0.3 %

Shares of NASDAQ CLBT opened at $19.12 on Monday. Cellebrite DI Ltd. has a twelve month low of $10.24 and a twelve month high of $26.30. The company has a market capitalization of $3.94 billion, a PE ratio of -13.76, a P/E/G ratio of 4.27 and a beta of 1.47. The firm has a fifty day simple moving average of $22.54 and a 200 day simple moving average of $19.47.

Cellebrite DI (NASDAQ:CLBT) last posted its quarterly earnings results on Thursday, February 13th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.10 by ($0.03). Cellebrite DI had a negative net margin of 70.54% and a positive return on equity of 58.70%. As a group, equities analysts expect that Cellebrite DI Ltd. will post 0.3 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

CLBT has been the subject of a number of analyst reports. JPMorgan Chase & Co. raised their price target on shares of Cellebrite DI from $24.00 to $28.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 11th. Lake Street Capital raised their price target on shares of Cellebrite DI from $17.00 to $26.00 and gave the company a “buy” rating in a report on Friday, February 14th. Needham & Company LLC reissued a “buy” rating and issued a $28.00 price target on shares of Cellebrite DI in a report on Friday, February 14th. Finally, Craig Hallum lifted their target price on shares of Cellebrite DI from $23.00 to $24.00 and gave the stock a “buy” rating in a report on Thursday, November 7th. Eight equities research analysts have rated the stock with a buy rating, According to MarketBeat, Cellebrite DI currently has a consensus rating of “Buy” and a consensus price target of $23.43.

Cellebrite DI Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.